Form 4: Pfizer Executive Vice President Rady A. Johnson Reports Changes in Beneficial Ownership

Rady A. Johnson, Executive Vice President of Pfizer Inc., reports changes in beneficial ownership due to the acquisition of phantom stock units under the company's Supplemental Savings Plan.

Summary

• On December 31, 2024, Rady A. Johnson, an Executive Vice President at Pfizer Inc., reported changes in beneficial ownership.
• The changes involve the acquisition of 7 phantom stock units under the Pfizer Supplemental Savings Plan (SSP).
• These units are equivalent to shares of Pfizer common stock and were acquired at a price of $26.53 per unit.
• Following the transaction, Johnson directly owns 9,379 derivative securities.
• The reporting person ceased being an Officer on 12/31/2024.
• The phantom stock units are settled in cash upon separation from service and can be transferred to an alternative investment account at any time.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects routine executive compensation and alignment of interests with shareholders through stock ownership. There are no indications of negative events or concerns.

Positives

• The acquisition of phantom stock units aligns the executive's interests with the company's performance.
• The Pfizer Supplemental Savings Plan provides a mechanism for executives to accumulate wealth tied to the company's stock performance.

Future Outlook

The phantom stock units will be settled in cash following the reporting person's separation from service.

Industry Context

Form 4 filings are standard practice for corporate insiders to report transactions in their company's securities, ensuring transparency and compliance with SEC regulations.

Management Changes

Stakeholder Impact

• The acquisition of phantom stock units aligns executive compensation with shareholder value, potentially incentivizing performance.
• The disclosure provides transparency to shareholders regarding executive stock ownership.

Key Dates